By Product
Currency:CNY
2025/H1
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2010/FY
2010/H1
2009/FY
2009/H1
2008/FY
2008/H1
2007/FY
2007/H1
2006/FY
2006/H1
2005/FY
2005/H1
2004/FY
2004/H1
2003/FY
2003/H1
2002/FY
2002/H1
2001/FY
2001/H1
2000/FY
Stock NameRevenueRatio
Genetically engineered drugs\ biological drugs5.75B87.11%
Real estate449.87M6.81%
Chinese patent medicine377.71M5.72%
Service industry23.75M0.36%
By Industry
Currency:CNY
2025/H1
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2010/FY
2010/H1
2009/FY
2009/H1
2008/FY
2008/H1
2007/FY
2007/H1
2006/FY
2006/H1
2005/FY
2005/H1
2004/FY
2004/H1
2003/FY
2003/H1
2002/FY
2002/H1
2001/FY
2001/H1
2000/FY
Stock NameRevenueRatio
Pharmaceutical industry6.13B92.83%
Real estate449.87M6.81%
Service industry23.75M0.36%
By Country/Region
Currency:CNY
2025/H1
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2010/FY
2010/H1
2009/FY
2009/H1
2008/FY
2008/H1
2007/FY
2007/H1
2006/FY
2006/H1
2005/FY
2005/H1
2004/FY
2004/H1
2003/FY
2003/H1
2002/FY
2002/H1
2001/FY
Stock NameRevenueRatio
East China region2.55B38.68%
South China839.03M12.71%
Northeast area787.45M11.93%
Central China723.85M10.96%
Southwest area722.22M10.94%
North China659.27M9.98%
Northwest region241.97M3.66%
Abroad74.89M1.13%
View all
